Colgate-PalmoliveCoca-Cola Europacific Partners

Colgate-Palmolive vs Coca-Cola Europacific Partners

Colgate-Palmolive vs Coca-Cola Europacific Partners sets a household staples giant against a major bottling and distribution powerhouse, two companies that depend on massive operational scale and deep...

Why It's Moving

Colgate-Palmolive

CL Stock Warning: Why Analysts See -8% Downside Risk

  • TD Cowen slashed its 2026 EPS growth forecast to 4%, below consensus 5%, as tallow prices spiked 40% year-over-year, threatening profit margins in a high-inflation environment.
  • Insiders dumped $17.49M in shares over three months, with the COO reducing holdings by 77% and CFO by 64%, signaling potential doubts on short-term upside.
  • Mixed analyst views persist, with Deutsche Bank upgrading to Buy at $98, but cost headwinds and a weaker U.S. segment start to 2026 fuel the bearish outlook.
Sentiment:
🐻Bearish
Coca-Cola Europacific Partners

CCEP Stock Warning: Why Analysts See -3% Downside Risk

  • Exceptional 22.1:1 risk-reward short opportunity eyes $96.07 target with just 0.3% risk, signaling overbought conditions in a mid-channel oscillation.
  • Neutral near-term signals (1-5 days) cluster between $100.66 support and $101.88 resistance, while mid-term (5-20 days) turns weak at $97.77 support.
  • Ongoing €1 billion buyback program continues with recent repurchases like 320,898 shares March 30-April 2, yet fails to counter bearish technical momentum.
Sentiment:
🐻Bearish

Investment Analysis

Pros

  • Colgate-Palmolive achieved organic sales growth of 2.4% in Q2 2025, demonstrating resilience despite inflation and foreign exchange headwinds.
  • The company maintains a strong global market position in household and personal care products, supported by high gross profit margins of over 60%.
  • Colgate-Palmolive offers a stable dividend yield of around 2.7%, appealing to income-focused investors seeking consistent returns.

Considerations

  • The stock trades at a premium valuation, with a P/E ratio above sector average, which may limit upside for new investors.
  • Recent analyst price targets have been lowered, reflecting concerns about future growth and limited share price appreciation over the past year.
  • Colgate-Palmolive faces ongoing exposure to raw material cost pressures and currency volatility, which could impact profitability.

Pros

  • Coca-Cola Europacific Partners benefits from strong brand recognition and a dominant position in the European and Pacific beverage markets.
  • The company has demonstrated consistent revenue growth, supported by a diversified product portfolio and strategic distribution networks.
  • It maintains healthy operating margins and a solid return on equity, reflecting efficient capital allocation and operational discipline.

Considerations

  • The business is exposed to regulatory risks and changing consumer preferences, particularly around sugar content and health concerns.
  • Coca-Cola Europacific Partners faces competitive pressures from both global and local beverage brands, which could constrain pricing power.
  • The company's performance is sensitive to macroeconomic factors, including inflation and currency fluctuations, especially in its international markets.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive's next earnings release is scheduled for April 30, 2026, with some sources indicating May 1, 2026 before market open. The company will report results for the first quarter of 2026, with analysts estimating earnings per share of approximately $0.95. Given the current date of April 13, 2026, this earnings announcement is expected within the next two to three weeks. Investors should monitor for the official confirmation of the exact date and time from the company's investor relations department.

Coca-Cola Europacific Partners (CCEP) Next Earnings Date

Based on the available information, Coca-Cola Europacific Partners' next earnings date is estimated to fall between April 28, 2026 and May 19, 2026, as sources indicate differing projections for the Q1 2026 earnings report. The company has not yet officially announced the specific date, so this estimate is based on historical earnings release patterns. Investors should monitor CCEP's investor relations website for an official announcement, as the exact timing may vary slightly from these projections.

Buy CL or CCEP in Nemo

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

CL
CL$84.34
vs
CCEP
CCEP$97.43